CytoMed Therapeutics Limited Ordinary Shares (GDTC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $9.24M
Last updated: Nov 17, 2026 at 4:00 PM ET
CytoMed Therapeutics Limited Ordinary Shares (GDTC) Stock Chart
CytoMed Therapeutics Limited Ordinary Shares (GDTC) has a latest price of $0.78 on Nov 17, 2026, 63.1% below its 52-week high of $2.12. Its price fell 60.1% over the past 12 months. The month-end price fell 75.4% over the 3 years through Oct 2026, a compound annual decline of 37.3%.
Price Chart
From Apr 2023 to Oct 2026, its highest month-end close was $4.90 in Dec 2023 and its lowest $0.81 in Jan 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart GDTC with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GDTC.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 13.0%, and over 6 months it fell 35.3%.
| Period | Change |
|---|---|
| 1 month | -8.1% |
| 3 months | -13.0% |
| 6 months | -35.3% |
| 12 months | -60.1% |
| 12 months, with dividends | -60.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -75.4% | -37.3% |
Price by Year
Its best calendar year was 2024, when the price fell 30.6%, and its weakest was 2025, when it fell 60.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.92 | -31.2% |
| 2025 | $1.33 | -60.7% |
| 2024 | $3.40 | -30.6% |
Trading Range
The price is 11.5% below its 50-day average of $0.88 and 19.7% below its 200-day average of $0.97.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.78 | |
| 52-week high | $2.12 | -63.1% |
| 52-week low | $0.68 | +15.1% |
| 50-day average | $0.88 | -11.5% |
| 200-day average | $0.97 | -19.7% |
Price Risk
Over 3 years, its largest fall from a peak was 86.1%.
| Measure | Value |
|---|---|
| 1-year beta | 0.02 |
| Largest fall, 1 year | -63.5% |
| Largest fall, 3 years | -86.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About GDTC
What is GDTC's 1-year price change?
CytoMed Therapeutics Limited Ordinary Shares's price fell 60.1% over the past 12 months. With dividends included, the 12-month total return was -60.1%.
How has GDTC stock done over the long term?
CytoMed Therapeutics Limited Ordinary Shares's month-end price fell 75.4% over the 3 years through Oct 2026, a compound annual decline of 37.3%. These figures leave out dividends.
What is GDTC's 52-week high and low?
CytoMed Therapeutics Limited Ordinary Shares's 52-week high is $2.12 and its 52-week low is $0.68. Its latest price of $0.78 on Nov 17, 2026 is 63.1% below the high.
What is GDTC's beta?
CytoMed Therapeutics Limited Ordinary Shares's 1-year beta against the S&P 500 is 0.02, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 63.5%.
Is the GDTC chart free?
Yes. Advanced Charting for GDTC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
GDTC pages: Overview, Charting, Financials